Vestor Capital LLC Invests $2.89 Million in Valaris Limited (NYSE:VAL)

Vestor Capital LLC acquired a new stake in Valaris Limited (NYSE:VAL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 42,144 shares of the company's stock, valued at approximately $2,890,000. Vestor Capital LLC owned approximately 0.06% of Valaris as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in VAL. Fifth Third Bancorp increased its holdings in shares of Valaris by 120.1% during the 3rd quarter. Fifth Third Bancorp now owns 394 shares of the company's stock worth $30,000 after purchasing an additional 215 shares during the period. Princeton Global Asset Management LLC acquired a new position in Valaris in the third quarter worth about $37,000. Covestor Ltd lifted its stake in Valaris by 184.0% during the third quarter. Covestor Ltd now owns 693 shares of the company's stock worth $52,000 after purchasing an additional 449 shares during the period. Assetmark Inc. bought a new stake in shares of Valaris in the 3rd quarter valued at approximately $70,000. Finally, Spire Wealth Management acquired a new stake in Valaris in the 4th quarter valued at $101,000. 96.74% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

VAL has been the topic of several recent analyst reports. Barclays reduced their target price on shares of Valaris from $102.00 to $98.00 and set an "overweight" rating on the stock in a research note on Friday. Evercore ISI reduced their price target on shares of Valaris from $107.00 to $105.00 and set an "outperform" rating on the stock in a research report on Friday, February 23rd. Benchmark restated a "buy" rating and issued a $90.00 price objective on shares of Valaris in a research report on Thursday, May 2nd. TheStreet upgraded shares of Valaris from a "c" rating to a "b-" rating in a research report on Thursday, February 22nd. Finally, StockNews.com raised shares of Valaris to a "sell" rating in a report on Friday, April 26th. One equities research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, Valaris presently has a consensus rating of "Moderate Buy" and a consensus target price of $99.20.

Valaris Stock Down 2.3 %

VAL stock traded down $1.69 during mid-day trading on Friday, hitting $72.90. 699,627 shares of the company were exchanged, compared to its average volume of 789,549. Valaris Limited has a 1-year low of $55.53 and a 1-year high of $78.92. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.57 and a current ratio of 1.57. The firm's 50 day simple moving average is $70.40 and its 200 day simple moving average is $67.92. The firm has a market cap of $5.28 billion, a P/E ratio of 6.38 and a beta of 1.20.

Valaris (NYSE:VAL - Get Free Report) last posted its quarterly earnings data on Wednesday, May 1st. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). Valaris had a return on equity of 3.81% and a net margin of 44.93%. The firm had revenue of $525.00 million for the quarter, compared to analyst estimates of $503.00 million. On average, sell-side analysts predict that Valaris Limited will post 4.37 EPS for the current fiscal year.

Valaris Company Profile

Valaris Limited, together with its subsidiaries, provides offshore contract drilling services Gulf of Mexico, South America, North Sea, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Floaters, Jackups, ARO, and Other. It owns an offshore drilling rig fleet, which include drillships, dynamically positioned semisubmersible rigs, moored semisubmersible rig, and jackup rigs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.